161 related articles for article (PubMed ID: 17521745)
1. Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: consequences of recombinant feline interferon-omega administration.
Paltrinieri S; Crippa A; Comerio T; Angioletti A; Roccabianca P
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):68-74. PubMed ID: 17521745
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficacy of the subcutaneous low recombinant feline interferon-omega administration protocol for feline chronic gingivitis-stomatitis in feline calicivirus-positive cats.
Matsumoto H; Teshima T; Iizuka Y; Sakusabe A; Takahashi D; Amimoto A; Koyama H
Res Vet Sci; 2018 Dec; 121():53-58. PubMed ID: 30359811
[TBL] [Abstract][Full Text] [Related]
3. Immunological effects of recombinant feline interferon-omega (KT-80) administration in the dog.
Kuwabara M; Nariai Y; Horiuchi Y; Nakajima Y; Yamaguchi Y; Horioka E; Kawanabe M; Kubo T; Yukawa M; Sakai T
Microbiol Immunol; 2006; 50(8):637-41. PubMed ID: 16924149
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats.
Haid C; Kaps S; Gönczi E; Hässig M; Metzler A; Spiess BM; Richter M
Vet Ophthalmol; 2007; 10(5):278-84. PubMed ID: 17760705
[TBL] [Abstract][Full Text] [Related]
5. Effect of vaccination on parvovirus antigen testing in kittens.
Patterson EV; Reese MJ; Tucker SJ; Dubovi EJ; Crawford PC; Levy JK
J Am Vet Med Assoc; 2007 Feb; 230(3):359-63. PubMed ID: 17269866
[TBL] [Abstract][Full Text] [Related]
6. Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats.
Lappin MR; Andrews J; Simpson D; Jensen WA
J Am Vet Med Assoc; 2002 Jan; 220(1):38-42. PubMed ID: 12680445
[TBL] [Abstract][Full Text] [Related]
7. Clinical effects of the recombinant feline interferon-omega on experimental parvovirus infection in beagle dogs.
Ishiwata K; Minagawa T; Kajimoto T
J Vet Med Sci; 1998 Aug; 60(8):911-7. PubMed ID: 9764403
[TBL] [Abstract][Full Text] [Related]
8. Oral Recombinant Feline Interferon-Omega as an alternative immune modulation therapy in FIV positive cats: clinical and laboratory evaluation.
Gil S; Leal RO; McGahie D; Sepúlveda N; Duarte A; Niza MM; Tavares L
Res Vet Sci; 2014 Feb; 96(1):79-85. PubMed ID: 24332273
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant immunotherapy of feline fibrosarcoma with recombinant feline interferon-omega.
Hampel V; Schwarz B; Kempf C; Köstlin R; Schillinger U; Küchenhoff H; Fenske N; Brill T; Hirschberger J
J Vet Intern Med; 2007; 21(6):1340-6. PubMed ID: 18196745
[TBL] [Abstract][Full Text] [Related]
10. Limited efficacy of topical recombinant feline interferon-omega for treatment of cats with acute upper respiratory viral disease.
Ballin AC; Schulz B; Helps C; Sauter-Louis C; Mueller RS; Hartmann K
Vet J; 2014 Dec; 202(3):466-70. PubMed ID: 25457261
[TBL] [Abstract][Full Text] [Related]
11. Raccoon poxvirus feline panleukopenia virus VP2 recombinant protects cats against FPV challenge.
Hu L; Esposito JJ; Scott FW
Virology; 1996 Apr; 218(1):248-52. PubMed ID: 8615030
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of viremia, proviral load and cytokine profile in naturally feline immunodeficiency virus infected cats treated with two different protocols of recombinant feline interferon omega.
Leal RO; Gil S; Duarte A; McGahie D; Sepúlveda N; Niza MM; Tavares L
Res Vet Sci; 2015 Apr; 99():87-95. PubMed ID: 25747956
[TBL] [Abstract][Full Text] [Related]
13. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.
Jas D; Aeberlé C; Lacombe V; Guiot AL; Poulet H
Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649
[TBL] [Abstract][Full Text] [Related]
14. Activity of feline interferon-omega after ocular or oral administration in cats as indicated by Mx protein expression in conjunctival and white blood cells.
Bracklein T; Theise S; Metzler A; Spiess BM; Richter M
Am J Vet Res; 2006 Jun; 67(6):1025-32. PubMed ID: 16740097
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats.
de Mari K; Maynard L; Sanquer A; Lebreux B; Eun HM
J Vet Intern Med; 2004; 18(4):477-82. PubMed ID: 15320583
[TBL] [Abstract][Full Text] [Related]
16. Feline interferon-omega treatment on canine parvovirus infection.
Minagawa T; Ishiwata K; Kajimoto T
Vet Microbiol; 1999 Sep; 69(1-2):51-3. PubMed ID: 10515269
[TBL] [Abstract][Full Text] [Related]
17. [Parvovirus infections in cats in animal shelters].
Rehme T; Hartmann K; Bergmann M
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2023 Apr; 51(2):107-115. PubMed ID: 37230115
[TBL] [Abstract][Full Text] [Related]
18. Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega.
Litzlbauer P; Weber K; Mueller RS
Cytokine; 2014 Mar; 66(1):54-9. PubMed ID: 24548425
[TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant feline interferon-omega alone and in combination with chemotherapeutic agents on putative tumour-initiating cells and daughter cells derived from canine and feline mammary tumours.
Penzo C; Ross M; Muirhead R; Else R; Argyle DJ
Vet Comp Oncol; 2009 Dec; 7(4):222-9. PubMed ID: 19891692
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferation and colony-forming inhibition activities of recombinant feline interferon (rFeIFN) on various cells in vitro.
Priosoeryanto BP; Tateyama S; Yamaguchi R; Uchida K
Can J Vet Res; 1995 Jan; 59(1):67-9. PubMed ID: 7704845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
